Risk factors for central nervous system metastasis in patients with metastatic breast cancer

被引：0
|
作者：
Canfeza Sezgin
Erhan Gokmen
Mustafa Esassolak
Necmettin Ozdemir
Erdem Goker
机构：
[1] Ege University School of Medicine,Division of Medical Oncology
[2] Ege University School of Medicine,Department of Radiation Oncology
[3] Ege University School of Medicine,Department of Pathology
[4] Ege University School of Medicine,Tulay Aktas Oncology Hospital, Division of Medical Oncology
来源：
Medical Oncology | 2007年 / 24卷
关键词：
Breast cancer; central nervous system metastasis; lung metastasis; p53; risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：155 / 161
页数：6
相关论文
共 50 条
  • [1] Risk factors for central nervous system metastasis in patients with metastatic breast cancer
    Sezgin, Canfeza
    Gokmen, Erhan
    Esassolak, Mustafa
    Ozdemir, Necmettin
    Goker, Erdem
    MEDICAL ONCOLOGY, 2007, 24 (02) : 155 - 161
  • [2] Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms
    Cacho-Diaz, Bernardo
    Salmeron-Moreno, Karen
    Alvarez-Alvarez, Alejandra
    Georgina Mendoza-Olivas, Laura
    Alvarado-Miranda, Alberto
    Villarreal-Garza, Cynthia
    Reynoso-Noveron, Nancy
    Chavez-MacGregor, Mariana
    Abelardo Meneses-Garcia, Antelmo
    CANCER, 2020, 126 (15) : 3456 - 3463
  • [3] Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis
    Altundag, Kadri
    Bondy, Melissa L.
    Mirza, Nadeern Q.
    Kau, Shu-Wan
    Broglio, Kristine
    Hortobagyi, Gabriel N.
    Rivera, Edgardo
    CANCER, 2007, 110 (12) : 2640 - 2647
  • [4] Clinical presentation, risk factors and outcome of central nervous system metastasis vs stroke in cancer patients
    Cacho-Diaz, Bernardo
    Spinola-Marono, Hector
    Mendoza-Olivas, Laura G.
    CURRENT PROBLEMS IN CANCER, 2019, 43 (04) : 324 - 330
  • [5] Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy
    Marianne Ryberg
    Dorte Nielsen
    Kell Osterlind
    Per Kragh Andersen
    Torben Skovsgaard
    Per Dombernowsky
    Breast Cancer Research and Treatment, 2005, 91 : 217 - 225
  • [6] Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy
    Ryberg, M
    Nielsen, D
    Osterlind, K
    Andersen, PK
    Skovsgaard, T
    Dombernowsky, P
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 91 (03) : 217 - 225
  • [7] Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab:: Incidence, survival, and risk factors
    Gori, Stefania
    Rimondini, Simonetta
    De Angelis, Verena
    Colozza, Mariantonietta
    Bisagni, Giancarlo
    Moretti, Gabriella
    Sidoni, Angelo
    Basurto, Carlo
    Aristei, Cynthia
    Anastasi, Paola
    Crino, Lucio
    ONCOLOGIST, 2007, 12 (07): : 766 - 773
  • [8] Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab
    Montagna, E.
    Cancello, G.
    D'Agostino, D.
    Lauria, R.
    Forestieri, V.
    Esposito, A.
    Silvestro, L.
    Accurso, A.
    Placido, S. De
    Laurentiis, M. De
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 275 - 280
  • [9] Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab
    E. Montagna
    G. Cancello
    D. D’Agostino
    R. Lauria
    V. Forestieri
    A. Esposito
    L. Silvestro
    A. Accurso
    S. De Placido
    M. De Laurentiis
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 275 - 280
  • [10] Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival
    Miller, KD
    Weathers, T
    Haney, LG
    Timmerman, R
    Dickler, M
    Shen, J
    Sledge, GW
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1072 - 1077
12345